New Zealand markets closed

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
166.42+2.07 (+1.26%)
At close: 04:00PM EDT
166.38 -0.04 (-0.02%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 290.22B
Enterprise value 346.15B
Trailing P/E 48.91
Forward P/E 14.71
PEG ratio (5-yr expected) 0.43
Price/sales (ttm)5.35
Price/book (mrq)36.25
Enterprise value/revenue 6.36
Enterprise value/EBITDA 18.70

Trading information

Stock price history

Beta (5Y monthly) 0.59
52-week change 313.26%
S&P500 52-week change 326.36%
52-week high 3182.89
52-week low 3130.96
50-day moving average 3170.10
200-day moving average 3158.21

Share statistics

Avg vol (3-month) 35.62M
Avg vol (10-day) 34.74M
Shares outstanding 51.77B
Implied shares outstanding 61.77B
Float 81.76B
% held by insiders 10.10%
% held by institutions 172.69%
Shares short (30 Apr 2024) 414.48M
Short ratio (30 Apr 2024) 42.6
Short % of float (30 Apr 2024) 40.82%
Short % of shares outstanding (30 Apr 2024) 40.82%
Shares short (prior month 28 Mar 2024) 413.12M

Dividends & splits

Forward annual dividend rate 46.2
Forward annual dividend yield 43.77%
Trailing annual dividend rate 36.06
Trailing annual dividend yield 33.69%
5-year average dividend yield 44.40
Payout ratio 4178.27%
Dividend date 315 May 2024
Ex-dividend date 412 Apr 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 11.02%
Operating margin (ttm)28.29%

Management effectiveness

Return on assets (ttm)7.71%
Return on equity (ttm)56.24%

Income statement

Revenue (ttm)54.4B
Revenue per share (ttm)30.77
Quarterly revenue growth (yoy)0.70%
Gross profit (ttm)N/A
Net income avi to common (ttm)5.95B
Diluted EPS (ttm)3.35
Quarterly earnings growth (yoy)472.80%

Balance sheet

Total cash (mrq)18.07B
Total cash per share (mrq)10.23
Total debt (mrq)74.36B
Total debt/equity (mrq)924.06%
Current ratio (mrq)0.94
Book value per share (mrq)4.53

Cash flow statement

Operating cash flow (ttm)22.69B
Levered free cash flow (ttm)23.61B